PMID: 25764685Mar 15, 2015Paper

Anti-HCV treatment for older patients

Nihon rinsho. Japanese journal of clinical medicine
Yasuhiro Asahina

Abstract

The prevalence of older patients has been increasing in Japan, and this is an impending problem in other countries where viral spread has occurred more recently. The risk for hepatocellular carcinoma (HCC) depended on age, and increased after 65 years of age. Even when stratified by stage of fibrosis, the cumulative and annual incidences of HCC were significantly higher in older patients than in younger patients (p < 0.001) at the same stage of fibrosis. The impact of hepatitis C viral (HCV) eradication on HCC prevention was less significant in older patients than in younger patients. Patients should therefore be identified at an earlier age and treatment should be initiated. Treatment strategy for older patients with HCV should be decided in consideration with interferon eligibility, response to interferon therapy, presence of resistant-associated variant in the NS5A, and risk of HCC.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Yasuhiro AsahinaNamiki Izumi
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Suresh D Sharma
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
Moutaz F DerbalaInas E El Defrawi
Journal of Gastroenterology and Hepatology
Yoshiyuki UenoGeoffrey C Farrell
© 2021 Meta ULC. All rights reserved